NANCY G COCOZZA
CIK 1232953 · Former Executive VP · last filed 2026-05-22
NANCY G COCOZZA is a Former Executive VP who has filed 13 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for PRVA, was dated May 22, 2026. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.00M
3
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRVA | Director | 42,814 | $23.43 | $1.00M | $0 | 5 | 2026-05-22 |
| Aspira Women's Health Inc. (AWH) Delisted | Director | 128,632 | $0.08 | $10.5K | $0 | 1 | 2021-03-23 |
| Aspira Women's Health Inc. (VRML) Delisted | Director | 129,506 | — | — | $0 | 4 | 2020-03-23 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | PRVA | Grant (A) | +8,463 | $0 | EDGAR |
| 2025-05-23 | PRVA | Grant (A) | +8,396 | $0 | EDGAR |
| 2024-05-23 | PRVA | Grant (A) | +11,124 | $0 | EDGAR |
| 2023-07-05 | PRVA | Grant (A) | +7,758 | $0 | EDGAR |
| 2022-04-05 | PRVA | Grant (A) | +7,073 | $0 | EDGAR |
| 2021-03-23 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | +15,680 | $0 | EDGAR |
| 2020-03-23 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +66,218 | $0 | EDGAR |
| 2020-03-23 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +66,218 | $0 | EDGAR |
| 2019-03-28 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +35,417 | $0 | EDGAR |
| 2018-08-21 | Aspira Women's Health Inc. (VRML) Delisted | Grant (A) | +27,871 | $0 | EDGAR |